Urovalve, a medical device company located in the NJIT Enterprise Development Center, has announced that President and CEO Harvey Homan PhD has been appointed to an advisory panel for urology and small business at the Center for Scientific Review (CSR) a division of the National Institutes of Health (NIH). Urovalve, a privately-held company, develops superior medical devices to address problems associated with urinary flow and control
The CSR evaluates the majority (70 percent) of the research grant applications sent to NIH.
“I am extremely proud to be appointed to serve the Center for Scientific Research,” said Homan. “CSR’s mission is to help NIH identify the most promising research for treating, curing and preventing disease, and I am certainly honored to serve that noble purpose.”
In fiscal year 2009, CSR reviewed 71,000 applications. Members of the CSR’s Urology Clinical and Small Business panel include distinguished professionals from Wake Forest School of Medicine, Stanford University School of Medicine, Children’s Hospital Boston, Baylor College of Medicine, Cleveland Clinic Foundation, Albert Einstein College of Medicine, University of Southern California, University of Pittsburgh and University of Chicago, among other eminent healthcare institutions.
Urovalve™, Inc. has developed and patented technology to control fluid flow through small diameter flexible tubing. The core proprietary technology for the Surinate® bladder management system is comprised of a simple magnetically controlled valve that can be activated remotely by a Surinate® wearer who uses a hand-held magnet to self-regulate flow. Currently available devices require continuous bladder drainage or insertion of a tube into the urethra several times each day.
The Enterprise Development Center at NJIT is New Jersey’s oldest and largest high-technology business incubator. The EDC gives early-stage start-ups an edge in meeting the many challenges of commercialization. Among the companies housed at the EDC are firms building marketplace success with breakthrough work in areas such as video e-learning, renewable energy, products in the life sciences for medical diagnosis and therapy, information technology, telecommunications and advanced materials.